Complications Related to Cardiac Rhythm Management Device Therapy and Their Financial Implication: A Prospective Single-Center Two-Year Survey

Cardiac rhythm management devices (CRMDs) have proven their clinical effectiveness for patients with heart rhythm disorders. Little is known about safety and complication rates during the implantation of these devices. This study demonstrated the complication rates related to CRMD implantation, and...

Full description

Bibliographic Details
Main Authors: John Fanourgiakis, Emmanuel Simantirakis, Nikolaos Maniadakis, Emmanuel Kanoupakis, Stavros Chrysostomakis, Georgia Kourlaba, Gregory Chlouverakis, Panos Vardas
Format: Article
Language:English
Published: Elsevier 2016-01-01
Series:Hellenic Journal of Cardiology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1109966616300161
_version_ 1828337969486888960
author John Fanourgiakis
Emmanuel Simantirakis
Nikolaos Maniadakis
Emmanuel Kanoupakis
Stavros Chrysostomakis
Georgia Kourlaba
Gregory Chlouverakis
Panos Vardas
author_facet John Fanourgiakis
Emmanuel Simantirakis
Nikolaos Maniadakis
Emmanuel Kanoupakis
Stavros Chrysostomakis
Georgia Kourlaba
Gregory Chlouverakis
Panos Vardas
author_sort John Fanourgiakis
collection DOAJ
description Cardiac rhythm management devices (CRMDs) have proven their clinical effectiveness for patients with heart rhythm disorders. Little is known about safety and complication rates during the implantation of these devices. This study demonstrated the complication rates related to CRMD implantation, and estimated the additional hospital stay and cost associated with the management of complications. Methods: During a period of one year, a total of 464 consecutive recipients underwent CRMD implantation and were followed for 2 years. Finally, data were analyzed for 398 patients who completed the two-year follow up, resulting in a total of 796 patient-years. Results: Of the 201 patients with initial pacemaker (PM) implantations, 6 (2.99%) had seven complications (5 patients had lead dislodgement, 1 of them twice), and 1 patient developed pocket infection. Of the 117 PM replacements, 1 (0.85%) patient developed a complication (pocket erosion). Two patients with complications (1 with an initial PM and 1 with a replacement) died before completing the follow up for reasons unrelated to cardiac causes. There were no complications in either initial implantations (69 patients) or replacements (11 patients) of implantable cardioverter-defibrillators. The average prolongation of the hospital stay was 7 days, ranging from 1 to 35 days, resulting in €17,411 of total additional direct hospital costs. Conclusion: This study found relatively low rates of complications in patients undergoing CRMD implantation, initial or replacement, in our center, compared with other studies. The additional hospitalization days and costs attributable to these complications depend on the nature of the complication.
first_indexed 2024-04-13T22:22:04Z
format Article
id doaj.art-576a40d188f34d6c90250cb0197bb630
institution Directory Open Access Journal
issn 1109-9666
language English
last_indexed 2024-04-13T22:22:04Z
publishDate 2016-01-01
publisher Elsevier
record_format Article
series Hellenic Journal of Cardiology
spelling doaj.art-576a40d188f34d6c90250cb0197bb6302022-12-22T02:27:12ZengElsevierHellenic Journal of Cardiology1109-96662016-01-01571333810.1016/S1109-9666(16)30016-1Complications Related to Cardiac Rhythm Management Device Therapy and Their Financial Implication: A Prospective Single-Center Two-Year SurveyJohn Fanourgiakis0Emmanuel Simantirakis1Nikolaos Maniadakis2Emmanuel Kanoupakis3Stavros Chrysostomakis4Georgia Kourlaba5Gregory Chlouverakis6Panos Vardas7Department of Cardiology, Heraklion University Hospital, CreteDepartment of Cardiology, Heraklion University Hospital, CreteNational School of Public Health, AthensDepartment of Cardiology, Heraklion University Hospital, CreteDepartment of Cardiology, Heraklion University Hospital, CreteThe Stavros Niarchos Foundation-Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), AthensDepartment of Biostatistics, Faculty of Medicine, University of Crete, Crete, GreeceDepartment of Cardiology, Heraklion University Hospital, CreteCardiac rhythm management devices (CRMDs) have proven their clinical effectiveness for patients with heart rhythm disorders. Little is known about safety and complication rates during the implantation of these devices. This study demonstrated the complication rates related to CRMD implantation, and estimated the additional hospital stay and cost associated with the management of complications. Methods: During a period of one year, a total of 464 consecutive recipients underwent CRMD implantation and were followed for 2 years. Finally, data were analyzed for 398 patients who completed the two-year follow up, resulting in a total of 796 patient-years. Results: Of the 201 patients with initial pacemaker (PM) implantations, 6 (2.99%) had seven complications (5 patients had lead dislodgement, 1 of them twice), and 1 patient developed pocket infection. Of the 117 PM replacements, 1 (0.85%) patient developed a complication (pocket erosion). Two patients with complications (1 with an initial PM and 1 with a replacement) died before completing the follow up for reasons unrelated to cardiac causes. There were no complications in either initial implantations (69 patients) or replacements (11 patients) of implantable cardioverter-defibrillators. The average prolongation of the hospital stay was 7 days, ranging from 1 to 35 days, resulting in €17,411 of total additional direct hospital costs. Conclusion: This study found relatively low rates of complications in patients undergoing CRMD implantation, initial or replacement, in our center, compared with other studies. The additional hospitalization days and costs attributable to these complications depend on the nature of the complication.http://www.sciencedirect.com/science/article/pii/S1109966616300161Pacemakerimplantable cardioverter defibrillatorcomplications
spellingShingle John Fanourgiakis
Emmanuel Simantirakis
Nikolaos Maniadakis
Emmanuel Kanoupakis
Stavros Chrysostomakis
Georgia Kourlaba
Gregory Chlouverakis
Panos Vardas
Complications Related to Cardiac Rhythm Management Device Therapy and Their Financial Implication: A Prospective Single-Center Two-Year Survey
Hellenic Journal of Cardiology
Pacemaker
implantable cardioverter defibrillator
complications
title Complications Related to Cardiac Rhythm Management Device Therapy and Their Financial Implication: A Prospective Single-Center Two-Year Survey
title_full Complications Related to Cardiac Rhythm Management Device Therapy and Their Financial Implication: A Prospective Single-Center Two-Year Survey
title_fullStr Complications Related to Cardiac Rhythm Management Device Therapy and Their Financial Implication: A Prospective Single-Center Two-Year Survey
title_full_unstemmed Complications Related to Cardiac Rhythm Management Device Therapy and Their Financial Implication: A Prospective Single-Center Two-Year Survey
title_short Complications Related to Cardiac Rhythm Management Device Therapy and Their Financial Implication: A Prospective Single-Center Two-Year Survey
title_sort complications related to cardiac rhythm management device therapy and their financial implication a prospective single center two year survey
topic Pacemaker
implantable cardioverter defibrillator
complications
url http://www.sciencedirect.com/science/article/pii/S1109966616300161
work_keys_str_mv AT johnfanourgiakis complicationsrelatedtocardiacrhythmmanagementdevicetherapyandtheirfinancialimplicationaprospectivesinglecentertwoyearsurvey
AT emmanuelsimantirakis complicationsrelatedtocardiacrhythmmanagementdevicetherapyandtheirfinancialimplicationaprospectivesinglecentertwoyearsurvey
AT nikolaosmaniadakis complicationsrelatedtocardiacrhythmmanagementdevicetherapyandtheirfinancialimplicationaprospectivesinglecentertwoyearsurvey
AT emmanuelkanoupakis complicationsrelatedtocardiacrhythmmanagementdevicetherapyandtheirfinancialimplicationaprospectivesinglecentertwoyearsurvey
AT stavroschrysostomakis complicationsrelatedtocardiacrhythmmanagementdevicetherapyandtheirfinancialimplicationaprospectivesinglecentertwoyearsurvey
AT georgiakourlaba complicationsrelatedtocardiacrhythmmanagementdevicetherapyandtheirfinancialimplicationaprospectivesinglecentertwoyearsurvey
AT gregorychlouverakis complicationsrelatedtocardiacrhythmmanagementdevicetherapyandtheirfinancialimplicationaprospectivesinglecentertwoyearsurvey
AT panosvardas complicationsrelatedtocardiacrhythmmanagementdevicetherapyandtheirfinancialimplicationaprospectivesinglecentertwoyearsurvey